Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...

Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

H.C. Wainwright lowered the firm’s price target on Co-Diagnostics (CODX) to $1 from $1.50 and keeps a Neutral rating on the shares following the Q4 report. The firm cites the company’s higher ...

Shares of CODX stock opened at $0.32 on Friday. Co-Diagnostics has a twelve month low of $0.28 and a twelve month high of $2.23. The stock’s fifty day simple moving average is $0.61 and its 200 ...

likely played influential roles in the 11.57% stock price increase over the past quarter. The broader... Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced ...

The board of Quest Diagnostics Incorporated ( NYSE ... likely played influential roles in the 11.57% stock price increase over the past quarter. The broader... Aveanna (AVAH) was a big mover ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...